MARKET

FOLD

Amicus Therapeut
FOLD
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-164.8464
7.10
16.42
4,549,870,316.88
Amicus Completes Merger, Ends Nasdaq Listing and Reporting
TipRanks · 04/27 15:59
BioMarin completes Amicus acquisition for USD 14.5 per share, valuing deal at USD 4.8 billion
PUBT · 04/27 12:44
BioMarin resumed with an Overweight at Morgan Stanley
TipRanks · 04/27 10:21
Weekly Report: what happened at FOLD last week (0420-0424)?
Weekly Report · 04/27 09:12
NASDAQ TRADE HALT CONTINUES <FOLD.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
Reuters · 04/26 07:28
NASDAQ TRADE HALT <FOLD.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 04/24 23:50
BioMarin wins French FDI clearance for Amicus merger, closing expected April 27
PUBT · 04/23 20:52
Amicus Gains Final Approval for BioMarin Acquisition Completion
TipRanks · 04/23 20:41
More

Webull offers Amicus Therapeut stock information, including NASDAQ: FOLD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FOLD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FOLD stock methods without spending real money on the virtual paper trading platform.